Encephalitis Vaccines Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Encephalitis Vaccines Market Trends and the market is segmented by Vaccine Type (Mouse Brain-Derived Inactivated Vaccine, Cell Culture-Derived Inactivated Vaccine, Cell Culture-Derived Live Attenuated Vaccine), Indication Type (Japanese Encephalitis, Tick-Borne Encephalitis, Rabies Encephalitis), End-User (Child, and Adult), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Encephalitis Vaccines Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Encephalitis Vaccines Industry Overview

The encephalitis vaccine market is moderately competitive and consists of several major players. Strong manufacturing processes and significant investments in releasing improved vaccines in BRICS countries are opportunities in the market. Some of the companies which are currently dominating the market are Valneva SE., Bharat Biotech, BIKEN, Chengdu Institute of Biological Products Co., Ltd., Liaoning Cheng Bio Co., Ltd., GlaxoSmithKline Plc, Sanofi Pasteur, Tiantan Biological Product, Zhejiang Tianyuan Bio-Pharmaceutical.

Encephalitis Vaccines Market Leaders

  1. Valneva SE.

  2. Bharat Biotech

  3. BIKEN

  4. Pfizer Inc.

  5. GlaxoSmithKline

  6. *Disclaimer: Major Players sorted in no particular order
Encephalitis Vaccines Market Concentration

Encephalitis Vaccines Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?